Table 1 Basic characteristics of the randomized controlled trials included
Study and year | Country | Cancer position | R0 resection | Down-staging pCR of CRT | Journal publication |
|---|---|---|---|---|---|
Walsh, [27] | Ireland | Stomach | NM | 13(25.0%) | NEJM |
Esophagus | |||||
Urba, [30] | USA | Stomach | 90(92.8%) | 9(24.3%) | JCO |
Esophagus | |||||
TROG, [31] | Australia | Esophagus | 179(69.9%) | NM | Lancet Oncol |
CALGB9781, [28] | USA | Stomach | NM | 10(40.0%) | JCO |
Esophagus | |||||
Stahl, [33] | German | Stomach | 84(70.6%) | 7(11.7%) | JCO |
Burmeister, [32] | Australia | Stomach | 62(82.7%) | 5(12.8%) | EJC |
Esophagus | |||||
CROSS, [29] | Netherlands | Stomach | 259(70.8%) | 28(23.1%) | NEJM |
Esophagus |